NEWS PROVIDED BY ATAI Life Sciences Jul 09, 2020, 12:30 ET BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ — ATAI Life Sciences AG, a global biotechnology company builder that
Toronto, Ontario–(Newsfile Corp. – July 9, 2020) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”) is pleased to announce that further
NEWS PROVIDED BY Nova Mentis Life Science Corp. Jul 08, 2020, 08:00 ET VANCOUVER, BC, July 8, 2020 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA)
Toronto, Ontario–(Newsfile Corp. – July 8, 2020) – Osoyoos Cannabis Inc. (CSE: OSO) (“Osoyoos” or the “Company”) today provided a corporate update on its previously
With 18 months of experience providing access to safe, legal, and medically-supervised psychedelic experiences, Synthesis is on a mission to connect, bolster and empower the
Former UK Government Drug TSAR Appointed as Chairman of Scientific Advisory Board Toronto, Ontario–(Newsfile Corp. – July 7, 2020) – AWAKN Life Sciences Inc. (“AWAKN”)
We spoke to Steve Sadoff, CEO of newly-formed CannaGlobal Wellness, about his plans in the psychedelic space.
We spoke to Spencer Hawkswell, Executive Director of TheraPsil: a non-profit advocacy group seeking to facilitate legal access to psilocybin therapy for terminally-ill patients.
We spoke to JR Rahn, Co-Founder, Director & Co-CEO of MindMed. We asked JR about his Company’s clinical trials, how COVID-19 has affected their operations,
We provide information, research, news and interviews from the emergent psychedelic sector in one place. Cut through the ‘shroom stock’ noise with Psilocybin Alpha.
Industry insights and interviews delivered to your inbox. No spam, just valuable information.
© Psilocybin Alpha 2020